Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2026 Feb 4;20(2):e0013421. doi: 10.1371/journal.pntd.0013421

Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand

Metawee Thongdee 1, Somjit Chaiwattanarungruengpaisan 1, Weena Paungpin 1, Sivapong Sungpradit 2, Sineenard Jiemtaweeboon 3,4, Ekasit Tiyanun 5, Kanin Ruchisereekul 6, Sarin Suwanpakdee 1,3, Janjira Thaipadungpanit 7,8,*
Editor: Brianna R Beechler9
PMCID: PMC12871963  PMID: 41637464

Abstract

Pathogenic species of the genus Leptospira cause an underdiagnosed zoonosis in humans and animals called leptospirosis. Animal reservoirs often remain asymptomatic yet shed the active spirochete in urine, making the control of leptospirosis transmission to humans more challenging. Asymptomatic leptospirosis in human companions, such as dogs and cats, resulting in unrecognised infections, has been demonstrated in a few countries. Crucially, the current lack of molecular epidemiology data on Leptospira among companion animals in Thailand underscores the urgent need to investigate transmission dynamics for effective regional control. We investigated the prevalence of Leptospira infection in cats and dogs during neutering in seven provinces across Thailand. The urine samples were screened for Leptospira DNA by PCR targeting the rrs gene and further speciation using the Sanger Sequencing Analysis. The 56/567 (9.9%) animals were positive for Leptospira in the Pathogen clade, including 34/303 (11.2%) dogs and 22/264 (8.3%) cats. The partial rrs gene analysis identified L. interrogans, L. weilii, and L. borgpetersenii (4.4%) as well as Pathogen subclade 2 species (1.4%). Notably, this study reports the first molecular detection of L. yasudae (1.0%) in companion animals in Thailand. The identification of these three key pathogenic Leptospira species, common causes of human leptospirosis in Southeast Asia, in clinically healthy owned and free-roaming dogs and cats, suggests the risk of human leptospirosis in the areas investigated. These companion animals, often living in close contact with human, may contribute to daily risks. Therefore, enhanced surveillance and vaccination programs for dogs and cats, coupled with targeted public awareness campaigns, are critical for mitigating the risk of human infections.

Author summary

Leptospirosis, a neglected zoonotic disease caused by pathogenic species of genus Leptospira, can be transmitted to humans through contact with infected animal body fluids or contaminated environments. Free-ranging dogs and cats can shed infectious Leptospira in their urine, posing a significant risk. In Thailand, animal vaccine coverage for diseases like leptospirosis in these animals is unknown and unregulated, raising concerns about zoonotic transmission and reflecting a lack of routine veterinary support. Our study joined non-profit, volunteer-led neutering programs that travel to various provinces, offering free services for owned and unowned pets. This allowed our team to collect urine specimens directly from the urinary bladder for the detection of Leptospira. We found nearly 10% of the recruited asymptomatic dogs and cats were infected by the molecular screening assay. Three pathogenic Leptospira species, commonly infecting humans globally, were identified. Notably, we report the first detection of L. yasudae in animal urine samples, providing evidence of infectivity for a species not previously recognised for its pathogenicity and typically reported from the environment. This highlights the risk of human leptospirosis from contact with cats and dogs, emphasising the need for public awareness and annual vaccination programs for all pets.

Introduction

The genus Leptospira comprises Gram-negative spirochetes. The primary pathogenic species that cause human leptospirosis worldwide are L. interrogans and L. borgpetersenii [1,2]. Many mammals, including rodents, dogs, cats, pigs, bats, and cattle, serve as reservoir hosts for spirochetes, harbouring the bacteria in their proximal renal tubules without showing clinical signs [3,4]. They excrete living bacteria in their urine, which can transmit the disease through direct or indirect exposure to contaminated environments [3–5]. Disease severity depends on bacterial virulence, inoculum size and host immunity [5].

Of 68 species in the genus Leptospira, 40 are categorised into the Pathogen (P) clade, based on whole genome sequence analysis [6–12]. The P clade comprises two subclades (P1 and P2). Of the 19 species in subclade P1, eight (including L. interrogans, L. weilii and L. borgpetersenii) are key species that cause leptospirosis worldwide. The other eleven species (including L. alstonii, L. kmetyi and L. yasudae) are recently discovered species isolated from environmental samples, with no evidence of human or mammalian infections. Of 21 species of the P2, five (including L. wolffii and L. licerasiae) have been known as the intermediate group, causing mild leptospirosis in mammals and humans [11,13–17].

Human leptospirosis was commonly reported in tropical and subtropical regions [18,19]. In 2015, Costa et al. estimated over 1 million global human infections and more than 58,000 fatal cases (using data from 1970 to 2008) [18]. In Thailand, 24,378 human patients were reported to the Bureau of Epidemiology, Ministry of Public Health between 2017 and 2021 (average incidence rate of 3.6 per 100,000 population per year) [20]. The incidence rates in the lower northeastern (11.5 per 100,000 population per year) and upper southern (9.7 per 100,000 population per year) regions were higher than those in other regions of Thailand. Computational models showed that leptospirosis transmission is amplified by environmental changes, specifically increased rainfall and flood exposure. Furthermore, using diverse and potentially contaminated household water sources and occupational contact with moist soil, environmental water, or infected animals significantly raise the risk for all hosts (animals and humans) [21–23].

Leptospirosis in animals can pose a public health threat, as asymptomatic infected animals can spread living bacteria through urination, contaminating habitats and foraging areas where humans live, travel, or work. The more exposure to a variety of probable infection sources, the higher the risk of infections, which shows the complexity of disease control [24,25]. Companion animals, especially free-roaming dogs and cats, act as a critical bridge for Leptospira transmission. They acquire pathogens from primary reservoirs, such as rodents and contaminated environments, and then introduce them into households, where the disease can be passed to owners through close, intimate exposures. In Thailand, the pet population was estimated at over 12 million between 2019 and 2020, with a high-risk group of approximately one million free-roaming animals [26–29]. The prevalence of Leptospira carriage in free-roaming and client-owned animals varies across the country’s geographic regions [30–32].

Leptospira infections (symptomatic or asymptomatic) have been reported in many countries using PCR or culture, with median rates of 7.3% (IQR = 4.4-15.7%) in dogs and 6.3% (IQR = 3.3-22.1%) in cats since 2003 [30–70]. However, cross-sectional studies of asymptomatic Leptospira infections and carriages in dogs and cats in Thailand are scarce [30–32]. A variety of Leptospira P1 species are commonly reported globally. For instance, L. interrogans and L. borgpetersenii have been found in both dogs (0.4-16% vs 0.5-1%) [25,31,33,34,36,37,41,42,47–52,55–57,71] and cats (2–5% vs 0.7-7%) [58,61–64,70], while other species like L. weilii (1–3%) [31,33], L. santarosai (0.5-37%) [42,50,54,57], L. noguchii (2–37%) [25,50], L. kirschneri (0.4%) [52] and L. kmetyi (3–10%) [33,48] were found predominantly in dogs. In comparison, the P2 (L. wolffii and L. licerasiae) infections were reported in 18% and 5% of dogs originating from Iran and Sri Lanka, respectively [48,71]. In this study, we aimed to determine the prevalence of Leptospira carriage in dogs and cats across three regions of Thailand, establishing current molecular epidemiological data essential for directly informing targeted leptospirosis control strategies.

Methods

Ethics statement

The collection and analysis of animal samples were conducted between 2020 and 2023 under the approval of the Institute for Animal Care and Use Committee, Faculty of Veterinary Science, Mahidol University (MUVS-2020-01-03). The national standard’s animal welfare guidelines were followed. Written informed consent for participation was obtained from the animals’ owners. For unowned or free-roaming dogs and cats collected from public areas (such as temples and schools), informed consent for a sample collection was obtained from the heads of each community. Laboratory protocols were approved by the Institutional Biosafety Committee of the Faculty of Veterinary Science, Mahidol University (IBC/MUVS-B-001/2564).

Sample size calculation

Sample size estimation was performed using ProMESA software version 2.3 (EpiCentre, Massey University, New Zealand) based on the previously reported leptospirosis prevalence at 10% [31] of dogs and 0.8% of cats [32] at a 95% confidence interval and a 0.2 acceptable relative error. We used the maximum of the generally recommended relative error as the unknown prevalence in the study regions. This resulted in a minimum sample size of 223 dogs and 236 cats, which was required for the study.

Study population

Clinically healthy dogs and cats underwent sterilisation through the neutering program of the Faculty of Veterinary Science, Mahidol University and nonprofit organisations. All owned (n = 271) and free-roaming/unowned (n = 296) dogs and cats were included in this study. The neutering program was carried out across seven provinces in central, western, and southern Thailand (Fig 1). The sex and estimated age of each animal were recorded.

Fig 1. Geographic distribution of dog and cat Leptospira infections (Panel A) and median annual human leptospirosis incidence (Panel B) in seven provinces of Thailand: Nakhon Sawan, Nakhon Pathom, and Samut Sakhon (Central); Tak, Kanchanaburi, and Prachuap Khiri Khan (West); and Ranong (South).

Fig 1

Infection frequencies in animals were identified using PCR and sequencing. Human leptospirosis incidence data (per 100,000 population) were reported by the Ministry of Public Health. Darker shades indicate higher prevalence/incidence. Base map shapefiles were obtained from the Humanitarian Data Exchange (https://data.humdata.org/dataset/cod-ab-tha)(available under the Creative Commons Attribution for Intergovernmental Organisations license--https://data.humdata.org/faqs/licenses).

Dog and cat urine collections and DNA preparations

Urine samples were collected during trips with the non-profit, volunteer-led neutering programs. These programs provided access to anesthetised animals from which urine samples were collected using sterilised urinary catheters before sterilisation surgery. We collected a single urine sample from each animal. Available urine volume in the urine blader was collected into a new sterile 50 ml tube and kept on ice upon collection. The urine samples were transported to laboratories at cool temperatures (2°C to 6°C) and then stored at -80°C until used for DNA preparation. Collected urine specimens’ volume ranged from 1-370 ml (median = 42 ml) in dogs and 0.8–108 ml (median = 9.5 ml) in cats, which depended on each animal’s size. The total volume of each collected sample contained in 50 ml tubes was centrifuged at 2,000 relative centrifugal force (RCF) for 10 minutes at 4°C to remove cells and debris. Then, the supernatant was transferred to a new sterile 50 ml tube and centrifuged again at 20,000 RCF for 30 minutes at 4°C to obtain a microorganism cell pellet for the DNA preparation using the Genomic DNA Mini Kit (blood and cultured cells) (Geneaid, New Taipei City, Taiwan) according to the manufacturer’s protocol. The extracted DNA samples were eluted using 30–40 μl of the elution buffer.

Identification of Leptospira species based on partial 16S rRNA sequences amplification and analysis

The nested PCR assay targeting the partial 16S rRNA sequences of the P1 and P2 was conducted as described previously [72], with modifications as described in S1 File. The expected 547-bp amplicons were visualised using 1.5% agarose gel electrophoresis. Then, the PCR products were purified from agarose gel using GenepHlow Gel/PCR Kit (Geneaid, New Taipei City, Taiwan). It was conducted as described in the manufacturer’s protocol. The purified products were sent to Bionics (South Korea) for the Sanger DNA Sequencing.

The chromatogram results were inspected and edited for consensus using BioEdit Sequence Alignment Editor version 7.0.5.3. Maximum likelihood trees were reconstructed from the trimmed 443-nucleotide partial 16S rRNA gene alignments (from position 63–505 based on L. alexanderi GenBank accession number: NR_043047.1) using MEGA software version 11 [73]. The details of the algorithm used for the analysis were described in the S1 File. All sequences from this study (accession numbers: OQ446624-OQ446662)(S1 Table) and the 57 reference sequences of 40 Leptospira spp. acquired from GenBank data used for the analysis, (S2 Table). The phylogenetic tree was displayed and annotated using the Interactive Tree Of Life version 6.0 [74].

Statistical analysis

Data management was performed using Microsoft Excel, and statistical analyses were conducted using R version 4.0.3 [75]. The prevalence of Leptospira spp. infection was stratified by sex, age group, ownership, and study site. To determine the strength of associations between prevalence and exposure factors, Odds Ratios (ORs) and 95% confidence intervals (CIs) were calculated using the ‘epitools’ package for R [76]. Small-sample adjustments were applied to both OR estimates and CIs (using a normal approximation), and p-values were derived using Fisher’s exact test. Statistical significance was defined as a p-value < 0.05 and a 95% CI that did not include 1. Adjustments for multiple comparisons were not applied, as the primary objective was to estimate the magnitude of associations rather than strictly test hypotheses. Finally, the geographical distribution of Leptospira prevalence was visualised via choropleth mapping using the ggplot2 and sf packages in R. Base map shapefiles for Thailand’s administrative boundaries were obtained from the Humanitarian Data Exchange (URL: https://data.humdata.org/dataset/cod-ab-tha), sourced from the Royal Thai Survey Department. The maps were plotted with Leptospira spp. carriage among dogs and cats (data from this study) and human leptospirosis incidence in Thailand (S2 File)

Results

Asymptomatic Leptospira infections in dogs and cats

A total of 567 animals, comprising 303 dogs (53.4%) and 264 cats (46.6%), clinically healthy, were recruited into the study during the neutering service. They originated from seven provinces in three regions of Thailand, with the infection frequencies shown in Fig 1. The 5/7 provincial sites show infections ranging from 1% to 16% of the recruited animals. The infection rates are likely underestimated because the study design only detects chronic carriers (leptospiruria) and is subject to the inherent challenge of intermittent bacterial shedding in the urine.

The overall Leptospira infection prevalence was 11.2% (34/303) in dogs and 8.3% (22/264) in cats. In both animal types, statistical analysis revealed no significant differences in prevalence by sex, age group, or ownership status (Table 1). Although age was not statistically significant, no infections were detected in juvenile cats, compared with an 8.8% rate in adults. Geographical location was a significant predictor of infection for dogs. Dogs in Tak and Prachuap Khiri Khan exhibited significantly higher infection risks compared to the Nakhon Pathom site (p < 0.05).

Table 1. Distributions of leptospirosis in dogs and cats stratified by study sites, sex, age group and ownership.

Demography Dogs Cats
n infected
(%)
Total
(n)
Odds ratio
(95%CI)
P- value n infected
(%)
Total
(n)
Odds ratio
(95%CI)
P- value
Animalsa (n=567) 34 (11.2) 303 1.325 (0.789-2.412) 0.2623 22 (8.3) 264 ref
Study site a
 Nakhon Sawan (n=40) 0 20 n/a n/a 0 20 n/a n/a
 Samut Sakhon (n=12) 0 0 n/a n/a 0 12 n/a n/a
 Nakhon Pathom (n=76) 1 (1.4) 74 ref 0 2 n/a n/a
 Kanchanaburi (n=43) 1 (4.5) 22 1.659 (0.338-34.566) 0.408 1 (4.8) 21 ref
 Tak (n=56) 5 (20.8) 24 9.125 (2.123-89.954)* # 0.003* 4 (12.5) 32 1.379 (0.312-14.913) 0.637
 Prachuap Khiri  Khan (n=102) 18 (32.7) 55 17.290 (4.373-133.623)* # <0.001* 9 (19.1) 47 2.308 (0.556-20.472) 0.157
 Ranong (n=238) 9 (8.3) 108 3.285 (0.814-26.874) 0.050 8 (6.2) 130 0.6504 (0.157-5.724) 1.000
Sex b
 Male (n=181) 10 (8.8) 114 ref 5 (7.5) 67 ref
 Female (n=353) 23 (12.8) 179 1.385 (0.693-3.223) 0.345 17 (9.8) 174 1.1118 (0.464-3.439) 0.803
 Missing (n=33) 1 (10) 10 0.946 (0.310-1.443) 1.000 0 23 n/a n/a
Age b
 Junior (n=46) 2 (6.1) 33 ref 0 13 n/a n/a
 Adult (n=521) 32 (11.9) 270 1.384 (0.450-6.550) 0.556 22 (8.8) 251 n/a n/a
Ownership b
 Owned (n=271) 11 (10.2) 108 ref 12 (7.4) 163 ref
 Free-roaming (n=296) 23 (11.8) 195 1.075 (0.547-2.440) 0.709 10 101 1.263 (0.588-3.288) 0.497

aCalculate the odds ratio by the small sample adjustment and comparing odds to the least animal Leptospira infection prevalence in dog or cat samples.

bThe odds ratio (the small sample adjustment) of dog and cat leptospirosis between the two provinces in the study, using the lowest prevalence as a reference. While sex, age and ownership parameters, male, junior and owned were used as references, respectively.

*Notify the statistically significant:p-value less than 0.05, which was calculated using Fisher’s exact method, and the entire range of the 95% confidence interval is more than 1 or less than 1, which was calculated using normal approximation with the small sample adjustment.

#The large interval of 95% confidence intervals suggests a limitation due to the small sample size.

National annual incidence data reported in those seven provinces (S1 File) indicate that Ranong had the highest human leptospirosis incidence (median 36.04 cases per 100,000 population), nearly 22-fold higher than Tak (1.65/100,000)(Fig 1). In contrast, our study found the highest leptospirosis prevalence in dogs and cats in Prachuap Khiri Khan (26.5%) and Tak (16.1%).

Leptospira pathogen clade detected in dogs and cats

The ML tree analysis revealed that 39/56 PCR-positive dogs and cats were infected with Leptospira subclade P1 and P2 (S1 File). Five distinct clusters were identified (Fig 2): Interrogans (46%), Borgpetersenii (13%), Weilii (5%), Yasudae (15%) and undetermined species of P2 (21%). The P2 classifications, based on rrs sequence polymorphisms and the distribution of infection, are detailed in S1 File. The distributions of each subclade are detailed in S3 Table.

Fig 2. Maximum Likelihood phylogenetic tree reconstructed using the partial 16S rRNA sequences of 39 nested PCR products amplified from urine samples of dogs (filled green triangles) and cats (not filled triangles).

Fig 2

There were 57 reference sequences of 40 Leptospira in the Pathogen clade, which were used to infer the species of amplicon sequences. The Leptospira sequences from this study were grouped into five clusters: L. interrogans (pink), L. borgpetersenii (yellow), L. weilii (orange), L. yasudae (green) and species in the Subclade 2 (grey) of the Pathogen clade. The sequences grouped in each cluster with a bootstrap value higher than 50% are indicated with a red star.

Geographically, P1-1 infections (L. interorgans, L. borgpetersenii and L. weilii) were most prevalent in animals from Tak (16.7% dogs vs 12.5% cats), followed by Ranong (6.5% vs 3.1%), Kanchanaburi (4.6% vs 4.8%), Prachuap Khiri Khan (3.6% vs 2.1%) and Nakhon Pathom (only 1.4% dogs) (Fig 3). Statistical analysis demonstrated that animals in Tak have a significantly higher risk of P1-1 infections than those in Nakhon Pathom (p-value = 0.005) (Table 2). L. yasudae (P1-2) was mainly detected in Prachuap Khiri Khan (5.5% vs 4.3%) and, to a lesser extent, in Ranong (0.8%, cats only). Animals from Prachuap Khiri Khan had a significantly higher risk of L. yasudae infections than those from Ranong (p-value = 0.010). The P2 cluster was most frequently found in Prachuap Khiri Khan (1.8% vs 6.4%), followed by Tak (4.2%, dogs only) and Ranong (0.9% vs 1.5%); the risk of P2 infection did not differ significantly among these three sites.

Fig 3. The funnel graph illustrates the distributions of Pathogen clade (P)- infected dogs (left) and cats (right) in five prevalence study sites, compared to infected animals (PCR-positive without molecular typing).

Fig 3

L. interrogans, L. borgpetersenii and L. weilii (belonging to Group 1 of the Subclade 1 in the P clade as P1-1), L. yasudae (belonging to Group 2 of the Subclade 1 as P1-2), and species in the Subclade 2 (P2) were in Panels A, B and C, respectively.

Table 2. Distribution of Leptospira Pathogen clade detected in dogs and cats in each study site.

P1-1
(%)
odds ratiob
(95%CI)
P
value
P1-2
(%)
odds ratio
(95%CI)
P
value
P2
(%)
odds ratiob
(95%CI)
P
value
Animala
(n = 567)
25 (4.4) 6 (1.1) 8 (1.4)
Study sites b
 Nakhon Sawan
(n = 40)
0 n/a 0 n/a 0 n/a
 Samut Sakhon
(n = 12)
0 n/a 0 n/a 0 n/a
 Nakhon Pathom
(n = 76)
1 (1.3) ref 0 n/a 0 n/a
 Kanchanaburi
(n = 43)
2 (4.7) 1.786 (0.387-23.775) 0.296 0 n/a 0 n/a
 Tak
(n = 56)
8 (14.3) 6.122 (1.498-51.936)* # 0.005* 0 n/a 1 (1.8) 1.049 (0.263-12.591) 0.573
 Prachuap Khiri Khan (n = 102) 3 (2.9) 1.125 (0.255-12.271) 0.637 5 (4.9) 6.046 (1.446-55.164)* # 0.010* 4 (3.9) 2.374 (0.746-12.673) 0.204
 Ranong (n = 238) 11 (4.6) 1.809 (0.455-14.227) 0.306 1 (0.4) ref 3 (1.3) ref
Gender b
 Male
(n = 181)
4 (2.2) ref 2 (1.1) ref 2 (1.1) ref
 Female
(n = 353)
21 (5.9) 2.232 (0.909-7.160) 0.054 4 (1.1) 0.682 (0.195-4.384) 1.000 6 (1.7) 1.029 (0.309-5.839) 0.723
 Missing
(n = 10)
0 n/a 0 n/a 0 n/a
Age b
 Junior
(n = 46)
0 n/a 1 (2.2) 1.870 (0.496-19.312) 0.400 1 (2.2) 1.397 (0.382-13.398) 0.494
 Adult
(n = 521)
25 (4.8) n/a 5 (1.0) ref 7 (1.3) ref
Ownership b
 Owned
(n = 271)
9 (3.3) ref 2 (0.7) ref 5 (1.8) ref
 Free-roaming
(n = 296)
16 (5.4) 1.492 (0.719-3.675) 0.306 4 (1.4) 1.224 (0.350-7.852) 0.688 3 (1.0) 1.372 (0.489-6.678) 0.489

For this table, P1-1 indicated three species: L. interrogans, L. borgpetersenii, and L. weillii, which belong to the Pathogen clade in Group 1 sub-group 1, while P1-2 indicated L. yasudae, which belongs to the Pathogen clade in Group 2 sub-group 2. The P2 indicated that the undetermined species belong to Pathogen Group 2.

aCalculate the odds ratio by small sample adjustment and comparing odds to the least pathogenic Leptospira groups’ prevalence in dog or cat samples.

bOdd ratio of the pathogenic Leptospira group between two provinces in the study, using the lowest prevalence as a reference. While sex, age and ownership parameters, male, junior and owned were used as references, respectively.

*Notify the statistically significant:p-value less than 0.05, which was calculated using Fisher’s exact method, and the entire range of the 95% confidence interval is more than 1 or less than 1, which was calculated using normal approximation with the small sample adjustment.

#The large interval of 95% confidence intervals suggests a limitation due to the small sample size

Discussion

This study reveals a critical public health risk: the shedding of pathogenic Leptospira in the urine of clinically healthy (asymptomatic) dogs and cats across central, western, and southern Thailand. Notably, 9.9% of these animals (11.2% dogs vs 8.3% cats) were identified as active shedders, posing a direct transmission risk to owners, other animals, and the environment. Regional analysis indicated that infection rates were lower in the central region compared to the western and southern regions. Given the national reports of human leptospirosis incidence, these findings suggest a potential for disease transmission from dogs and cats to humans within the same spatiotemporal context. However, companion animals are likely not the only sources of human infections in these provinces; other reservoirs (such as rodents and livestock) and environmental exposure via contaminated water or agricultural activities undoubtedly play significant roles in the transmission cycle.

The urinary shedding prevalence in this study was slightly higher than that reported in previous Thai studies [30–32,43]. In dogs, our findings were comparable to those from Malaysia, the USA and several European nations [34,38,41,45,47], but remain lower than the high-burden regions of South Asia, South America and Iran, where the prevalences ranged between 10.6% and 97.4% [33,37,39,42,46,48,50,53,56]. In cats, our prevalence fits within the broad international range of 0.3% to 12.9% reported in several countries of Asia, Europe, Latin America and the Caribbean [49,58,59,61–67,69], contrasting with the strikingly high prevalence reported in Taiwan (67.8%) [60]. Variations in the urinary shedding prevalence may be attributed to geographical location, study population, sample size, season, and screening techniques. The application of molecular methods to specifically identify pathogenic Leptospira DNA in clinically healthy carriers provides a crucial tool for monitoring transmission risks from these animals and informing targeted control strategies.

Several Leptospira spp. within the Pathogen Clade have been reported in asymptomatic dogs and cats worldwide. Commonly identified pathogenic species include L. interrogans, L. borgpetersenii, L. weilii, L. kirschneri, L. santarosai, and L. noguchii [25,31,33,34,36,37,41,42,47–55,57,58,60–64,68]. Among these, L. interrogans predominates in both dogs and cats from Malaysia [34,58] and is a primary species identified in North America & the Caribbean, South America, Europe, Africa Asia and Australia [25,33,36,37,42,47,52,55,58–60,62,63,68]. Consistent with these global trends, this study confirms that dogs and cats across Thailand carry these major pathogenic species. We identified L. interrogans, L. borgpetersenii, and L. weillii (which are the predominant causes of human leptospirosis in Thailand and neighbouring countries [77–84]) in dogs and cats during neutering procedures from western (Tak, Kanchanaburi, and Prachuap Khiri Khan), southern (Ranong), and central (Nakhon Pathom) regions.

Notably, beyond these established P1-1 pathogens, we report the first identification of L. yasudae (a species of undetermined virulence) in companion animals in western (Prachuap Khiri Khan) and southern (Ranong) Thailand. Furthermore, unspecified species of Leptospira within the P2 subclade (associated with mild diseases in humans [17]) was identified in southern (Ranong) and western (Tak and Prachuap Khiri Khan) regions.

We detected L. interrogans in similar proportions in urine samples from dogs (3.6%) and cats (2.7%). In contrast, a previous report from northern Thailand (Nan) detected urinary shedding of L. interrogans in 6.9% of dogs, but not in cats [31]. Conversely, a study in Songkhla (southern Thailand) found a higher prevalence of L. interrogans in cats compared to dogs (0.5% of dogs’ vs 7.8% of cats’ blood PCR-positive) [43]. Nan and Songkhla were provinces where human leptospirosis was a significant problem, particularly during the wet season [21,85]. The reasons for the variation in host infection rates across these areas remain unclear; further investigation is needed to determine if these host disparities result from local ecological exposure or sampling differences.

L. borgpetersenii, a common cause of bovine leptospirosis, was first isolated from US slaughter cattle [86]. However, L. borgpetersenii infections have also been identified in dogs and cats. Notably, the number reported among cats was higher than that among dogs. For example, 7.1% of cats were infected on Okinawa Island, Japan [64], and 4.5% in southern Italy [61]. In contrast, 1.1% of dogs in Sri Lanka [33] and 0.5% in Germany [41] were infected. To our knowledge, the identification of L. borgpetersenii infections among asymptomatic dogs and cats has been reported for the first time in Thailand: in central (Nakhon Pathom) and southern (Ranong) regions.

L. weilii infects a broad host range, including livestock, canines and wildlife [31,87,88]. In this study, L. weilii infections were found in dogs with a low prevalence of 0.7% (Kanchanaburi and Ranong) and were not identified in cats. This contrasts with the higher canine infection rates in northern Thailand (3.4%) [31] and Sri Lanka (1.1%) [33].

L. yasudae (conspecific with L. dzianensis [7]) was previously isolated solely from environmental samples, without documented reports of natural infection in humans or animals. Here, we provide the first description of L. yasudae infections in companion animals. Crucially, L. yasudae was detected in urine collected aseptically from the bladders, ruling out environmental contamination. These infections were identified predominantly in dogs and cats from Prachuap Khiri Khan and in a cat from Ranong.

Because of the limited diversity in the selected rrs sequences, Leptospira P2 could not be fully speciate. In stead, these undetermined species were classified into L. wolffii- or L. licerasiae-related groups (S1 File). Members of P2 have been primarily isolated from environmental samples worldwide, including Mayotte, Puerto Rico, Japan, and Thailand [12,82,89–91]. The potentially pathogenic L. wolffii was first documented in a patient from northeastern Thailand and subsequently identified in local rodents [17,92]. Recently, L. wolffii infections have been reported in other regions, including Iran and north-central Bangladesh, where it has reportedly replaced L. interrogans as a primary species [71,93–95]. In this study, we identified urinary shedding of the L. wolffii-related group in six animals from Ranong and Prachuap Khiri Khan. Similarly, L. licerasiae (associated with mild symptomatic infections) was first described in rats and humans in (or returning from) South America [96,97] and has since been detected in Australian swine and leptospirosis-vaccinated dogs in Sri Lanka [48,98]. We identified two animals carrying the L. licerasiae-related group in Tak and Ranong. These findings underscore the potential emergence of L. wolffii- and L. licerasiae-related infections in animal reservoirs in Thailand, as well as across South and Southeast Asia. Although the precise species within the P2 subclade infecting these dogs and cats remains undetermined, the broad geographical distribution of these reservoirs warrants further attention regarding their implications for animal and public health.

This study has several limitations to consider. First, the geographic scope and sample distribution were restricted. Sampling was limited to central, western, and southern Thailand, and sample sizes were unevenly distributed across sites (median = 41.5; range = 12–238). This imbalance may have reduced the statistical power to detect infections in sites with low recruitment, suggesting that these results may not fully represent the epidemiological situation in the northern or eastern regions of the country. Second, the reported prevalence likely underestimates the true infection rate. As our study focused on urinary shedding (leptospiruria) to identify chronic carriers, we did not perform blood sample investigation; consequently, animals in the acute phase of infection (where the pathogen is present in the blood but not yet shed in the urine) were not captured. Furthermore, because Leptospira are shed intermittently [25,42], a single-point urine collection may have yielded false-negative results for some carriers. Other factors also contribute to this underestimation, including potential false PCR negatives due to antibiotic administration before urine collection (a factor we could not fully control, though our neutering protocol did not use antibiotics). Third, logistical constraints impacted molecular identification. Due to limited field resources, samples were maintained at 2°C–6°C without pH neutralisation. The resulting exposure to potentially acidic urine, particularly in samples requiring prolonged transport (>24 hours) from distant sites, may have caused DNA degradation and reduced diagnostic sensitivity. Additionally, species identification was limited by low DNA yields and potential primer competition, leading to ambiguous Sanger sequencing reads. While the conserved 443 bp rrs gene fragment is a rapid method for identifying major P1 subclade species, it cannot accurately distinguish between members of the P2 subclade due to low genetic diversity in this region [9]. Future studies could achieve higher resolution for P2 species by targeting a more diverse set of markers, such as lipL32 and secY [89], or by employing next-generation deep sequencing.

In conclusion, three classical Leptospira species (L. interrogans, L. weilii, and L. borgpetersenii), responsible for human leptospirosis, were predominantly identified in dogs and cats in western and southern Thailand. Additionally, species potentially causing mild leptospirosis (L. wolffii- and L. licerasiae-related groups) and those with unknown infectivity (L. yasudae) were also detected. Our findings highlight the role of dogs and cats as reservoirs of pathogenic Leptospira spp., emphasising the need for expanded surveillance, broader-spectrum vaccines to reduce urinary shedding, and public awareness campaigns to mitigate zoonotic risk.

Supporting information

S1 File. Identification of Leptospira species.

(DOCX)

pntd.0013421.s001.docx (114.4KB, docx)
S2 File. Annual case and morbidity rate of study sites reported to the Department of Disease Control, Ministry of Public Health of Thailand, between 2019 and 2022.

(DOCX)

pntd.0013421.s002.docx (26.3KB, docx)
S1 Table. Demography characteristics of dogs and cats with urine specimens PCR-positive for pathogenic Leptospira.

(XLSX)

pntd.0013421.s003.xlsx (72.6KB, xlsx)
S2 Table. List of reference rrs sequences used for the 16S rRNA sequence analysis.

(XLSX)

pntd.0013421.s004.xlsx (68.4KB, xlsx)
S3 Table. Frequency of Leptospira groups in dogs and cats stratified by study site, age group, sex, and owned status.

(DOCX)

pntd.0013421.s005.docx (33KB, docx)

Acknowledgments

We are grateful to the staff of the One Health mobile unit, Faculty of Veterinary Science, Mahidol University, and all the volunteers from Soi Dog and the nonprofit organisations for their assistance with sample collection during the neutering process. We would also like to thank all the dog and cat owners who participated in this study.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

This work was funded by the Mahidol University (Award no. BRF1-A38/2564) to MT. The funders had no role in study design, data collection and analysis, publication decision, or manuscript preparation.

References

  • 1.WHO. Neglected tropical diseases, hidden successes, emerging opportunities. Geneva: WHO Press. 2009. https://www.who.int/publications/i/item/9789241598705 [Google Scholar]
  • 2.Karpagam KB, Ganesh B. Leptospirosis: a neglected tropical zoonotic infection of public health importance-an updated review. Eur J Clin Microbiol Infect Dis. 2020;39(5):835–46. doi: 10.1007/s10096-019-03797-4 [DOI] [PubMed] [Google Scholar]
  • 3.Adler B, de la Peña Moctezuma A. Leptospira and leptospirosis. Vet Microbiol. 2010;140(3–4):287–96. doi: 10.1016/j.vetmic.2009.03.012 [DOI] [PubMed] [Google Scholar]
  • 4.Haake DA, Levett PN. Leptospirosis in humans. Curr Top Microbiol Immunol. 2015;387:65–97. doi: 10.1007/978-3-662-45059-8_5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Evangelista KV, Coburn J. Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses. Future Microbiol. 2010;5(9):1413–25. doi: 10.2217/fmb.10.102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Casanovas-Massana A, Hamond C, Santos LA, de Oliveira D, Hacker KP, Balassiano I, et al. Leptospira yasudae sp. nov. and Leptospira stimsonii sp. nov., two new species of the pathogenic group isolated from environmental sources. Int J Syst Evol Microbiol. 2020;70(3):1450–6. doi: 10.1099/ijsem.0.003480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Casanovas-Massana A, Vincent AT, Bourhy P, Neela VK, Veyrier FJ, Picardeau M, et al. Leptospira dzianensis and Leptospira putramalaysiae are later heterotypic synonyms of Leptospira yasudae and Leptospira stimsonii. Int J Syst Evol Microbiol. 2019;71(3):004713. doi: 10.1099/ijsem.0.004713 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Fernandes LGV, Stone NE, Roe CC, Goris MGA, van der Linden H, Sahl JW, et al. Leptospira sanjuanensis sp. nov., a pathogenic species of the genus Leptospira isolated from soil in Puerto Rico. Int J Syst Evol Microbiol. 2022;72(10). doi: 10.1099/ijsem.0.005560 [DOI] [PubMed] [Google Scholar]
  • 9.Guglielmini J, Bourhy P, Schiettekatte O, Zinini F, Brisse S, Picardeau M. Genus-wide Leptospira core genome multilocus sequence typing for strain taxonomy and global surveillance. PLoS Negl Trop Dis. 2019;13(4):e0007374. doi: 10.1371/journal.pntd.0007374 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Korba AA, Lounici H, Kainiu M, Vincent AT, Mariet J-F, Veyrier FJ, et al. Leptospira ainlahdjerensis sp. nov., Leptospira ainazelensis sp. nov., Leptospira abararensis sp. nov. and Leptospira chreensis sp. nov., four new species isolated from water sources in Algeria. Int J Syst Evol Microbiol. 2021;71(12). doi: 10.1099/ijsem.0.005148 [DOI] [PubMed] [Google Scholar]
  • 11.Thibeaux R, Girault D, Bierque E, Soupé-Gilbert M-E, Rettinger A, Douyère A, et al. Biodiversity of Environmental Leptospira: Improving Identification and Revisiting the Diagnosis. Front Microbiol. 2018;9:816. doi: 10.3389/fmicb.2018.00816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Vincent AT, Schiettekatte O, Goarant C, Neela VK, Bernet E, Thibeaux R, et al. Revisiting the taxonomy and evolution of pathogenicity of the genus Leptospira through the prism of genomics. PLoS Negl Trop Dis. 2019;13(5):e0007270. doi: 10.1371/journal.pntd.0007270 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Abd Rahman AN, Hasnul Hadi NH, Sun Z, Thilakavathy K, Joseph N. Regional Prevalence of Intermediate Leptospira spp. in Humans: A Meta-Analysis. Pathogens. 2021;10(8):943. doi: 10.3390/pathogens10080943 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Chiani Y, Jacob P, Varni V, Landolt N, Schmeling MF, Pujato N, et al. Isolation and clinical sample typing of human leptospirosis cases in Argentina. Infect Genet Evol. 2016;37:245–51. doi: 10.1016/j.meegid.2015.11.033 [DOI] [PubMed] [Google Scholar]
  • 15.Chiriboga J, Barragan V, Arroyo G, Sosa A, Birdsell DN, España K, et al. High Prevalence of Intermediate Leptospira spp. DNA in Febrile Humans from Urban and Rural Ecuador. Emerg Infect Dis. 2015;21(12):2141–7. doi: 10.3201/eid2112.140659 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Perolat P, Chappel RJ, Adler B, Baranton G, Bulach DM, Billinghurst ML, et al. Leptospira fainei sp. nov., isolated from pigs in Australia. Int J Syst Bacteriol. 1998;48 Pt 3:851–8. doi: 10.1099/00207713-48-3-851 [DOI] [PubMed] [Google Scholar]
  • 17.Slack AT, Kalambaheti T, Symonds ML, Dohnt MF, Galloway RL, Steigerwalt AG, et al. Leptospira wolffii sp. nov., isolated from a human with suspected leptospirosis in Thailand. Int J Syst Evol Microbiol. 2008;58(Pt 10):2305–8. doi: 10.1099/ijs.0.64947-0 [DOI] [PubMed] [Google Scholar]
  • 18.Costa F, Hagan JE, Calcagno J, Kane M, Torgerson P, Martinez-Silveira MS, et al. Global Morbidity and Mortality of Leptospirosis: A Systematic Review. PLoS Negl Trop Dis. 2015;9(9):e0003898. doi: 10.1371/journal.pntd.0003898 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Victoriano AFB, Smythe LD, Gloriani-Barzaga N, Cavinta LL, Kasai T, Limpakarnjanarat K, et al. Leptospirosis in the Asia Pacific region. BMC Infect Dis. 2009;9:147. doi: 10.1186/1471-2334-9-147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Health Information System Development Office (HISO) D of DCM. Thai Health Stat. 2020. https://www.hiso.or.th/thaihealthstat/area/index.php?ma=1&pf=01818101&tm=2&tp=243
  • 21.Chadsuthi S, Chalvet-Monfray K, Geawduanglek S, Wongnak P, Cappelle J. Spatial-temporal patterns and risk factors for human leptospirosis in Thailand, 2012-2018. Sci Rep. 2022;12(1):5066. doi: 10.1038/s41598-022-09079-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Narkkul U, Thaipadungpanit J, Srisawat N, Rudge JW, Thongdee M, Pawarana R, et al. Human, animal, water source interactions and leptospirosis in Thailand. Sci Rep. 2021;11(1):3215. doi: 10.1038/s41598-021-82290-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Phosri A. Effects of rainfall on human leptospirosis in Thailand: evidence of multi-province study using distributed lag non-linear model. Stoch Environ Res Risk Assess. 2022;36(12):4119–32. doi: 10.1007/s00477-022-02250-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Almeida DS, Paz LN, de Oliveira DS, Silva DN, Ristow P, Hamond C, et al. Investigation of chronic infection by Leptospira spp. in asymptomatic sheep slaughtered in slaughterhouse. PLoS One. 2019;14(5):e0217391. doi: 10.1371/journal.pone.0217391 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Sant’Anna da Costa R, N Di Azevedo MI, Dos Santos Baptista Borges AL, Carvalho-Costa FA, Martins G, Lilenbaum W. Persistent High Leptospiral Shedding by Asymptomatic Dogs in Endemic Areas Triggers a Serious Public Health Concern. Animals (Basel). 2021;11(4):937. doi: 10.3390/ani11040937 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Pet TV. Pet parenting on the rise. https://www.thaipbsworld.com/pet-parenting-on-the-rise/. 2021. Accessed 2024 January 4.
  • 27.Puranabhandu OME. Thailand’s Pet Food Market. The United States Department of Agriculture, Foreign Agricultural Service. 2021. https://fas.usda.gov/data/thailand-thailands-pet-food-market [Google Scholar]
  • 28.Srimoragot PSP, Suwannaphirom P, Ruchisereekul K. Surveillance of knowledge, and opinion among pet’s owner on tobacco effect on pets’ health. J Mahanakorn Vet Med. 2021;16(1):63–75. [Google Scholar]
  • 29.Thanapongtharm W, Kasemsuwan S, Wongphruksasoong V, Boonyo K, Pinyopummintr T, Wiratsudakul A, et al. Spatial Distribution and Population Estimation of Dogs in Thailand: Implications for Rabies Prevention and Control. Front Vet Sci. 2021;8:790701. doi: 10.3389/fvets.2021.790701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Altheimer K, Jongwattanapisan P, Luengyosluechakul S, Pusoonthornthum R, Prapasarakul N, Kurilung A, et al. Leptospira infection and shedding in dogs in Thailand. BMC Vet Res. 2020;16(1):89. doi: 10.1186/s12917-020-2230-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kurilung A, Chanchaithong P, Lugsomya K, Niyomtham W, Wuthiekanun V, Prapasarakul N. Molecular detection and isolation of pathogenic Leptospira from asymptomatic humans, domestic animals and water sources in Nan province, a rural area of Thailand. Res Vet Sci. 2017;115:146–54. doi: 10.1016/j.rvsc.2017.03.017 [DOI] [PubMed] [Google Scholar]
  • 32.Sprißler F, Jongwattanapisan P, Luengyosluechakul S, Pusoonthornthum R, Prapasarakul N, Kurilung A, et al. Leptospira infection and shedding in cats in Thailand. Transbound Emerg Dis. 2019;66(2):948–56. doi: 10.1111/tbed.13110 [DOI] [PubMed] [Google Scholar]
  • 33.Athapattu T, Fernando R, Abayawansha R, Fernando P, Fuward M, Samarakoon N, et al. Carrier Status of Leptospira spp. in Healthy Companion Dogs in Sri Lanka. Vector Borne Zoonotic Dis. 2022;22(2):93–100. doi: 10.1089/vbz.2021.0065 [DOI] [PubMed] [Google Scholar]
  • 34.Benacer D, Thong KL, Ooi PT, Souris M, Lewis JW, Ahmed AA, et al. Serological and molecular identification of Leptospira spp. in swine and stray dogs from Malaysia. Trop Biomed. 2017;34(1):89–97. [PubMed] [Google Scholar]
  • 35.Delaude A, Rodriguez-Campos S, Dreyfus A, Counotte MJ, Francey T, Schweighauser A, et al. Canine leptospirosis in Switzerland-A prospective cross-sectional study examining seroprevalence, risk factors and urinary shedding of pathogenic leptospires. Prev Vet Med. 2017;141:48–60. doi: 10.1016/j.prevetmed.2017.04.008 [DOI] [PubMed] [Google Scholar]
  • 36.Gay N, Soupé-Gilbert M-E, Goarant C. Though not reservoirs, dogs might transmit Leptospira in New Caledonia. Int J Environ Res Public Health. 2014;11(4):4316–25. doi: 10.3390/ijerph110404316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Goy-Thollot I, Djelouadji Z, Nennig M, Hazart G, Hugonnard M. Screening for Leptospira DNA in blood and urine from 30 apparently healthy dogs. Revue Vétérinaire Clinique. 2018;53(3):79–86. doi: 10.1016/j.anicom.2018.06.003 [DOI] [Google Scholar]
  • 38.Harkin KR, Roshto YM, Sullivan JT, Purvis TJ, Chengappa MM. Comparison of polymerase chain reaction assay, bacteriologic culture, and serologic testing in assessment of prevalence of urinary shedding of leptospires in dogs. J Am Vet Med Assoc. 2003;222(9):1230–3. doi: 10.2460/javma.2003.222.1230 [DOI] [PubMed] [Google Scholar]
  • 39.Khorami N, Malmasi A, Zakeri S, Zahraei Salehi T, Abdollahpour G, Nassiri SM, et al. Screening urinalysis in dogs with urinary shedding of leptospires. Comp Clin Pathol. 2009;19(3):271–4. doi: 10.1007/s00580-009-0856-1 [DOI] [Google Scholar]
  • 40.Lau SF, Low KN, Khor KH, Roslan MA, Bejo SK, Radzi R, et al. Prevalence of leptospirosis in healthy dogs and dogs with kidney disease in Klang Valley, Malaysia. Trop Biomed. 2016;33(3):469–75. [PubMed] [Google Scholar]
  • 41.Llewellyn J-R, Krupka-Dyachenko I, Rettinger AL, Dyachenko V, Stamm I, Kopp PA, et al. Urinary shedding of leptospires and presence of Leptospira antibodies in healthy dogs from Upper Bavaria. Berl Munch Tierarztl Wochenschr. 2016;129(5–6):251–7. [PubMed] [Google Scholar]
  • 42.Miotto BA, Guilloux AGA, Tozzi BF, Moreno LZ, da Hora AS, Dias RA, et al. Prospective study of canine leptospirosis in shelter and stray dog populations: Identification of chronic carriers and different Leptospira species infecting dogs. PLoS One. 2018;13(7):e0200384. doi: 10.1371/journal.pone.0200384 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Ngasaman R, Saechan V, Prachantasena S, Yingkajorn M, Sretrirutchai S. Investigation of Leptospira Infection in Stray Animals in Songkhla, Thailand: Leptospirosis Risk Reduction in Human. Vector Borne Zoonotic Dis. 2020;20(6):432–5. doi: 10.1089/vbz.2019.2549 [DOI] [PubMed] [Google Scholar]
  • 44.Rohilla P, Khurana R, Kumar A, Batra K, Gupta R. Detection of Leptospira in urine of apparently healthy dogs by quantitative polymerase chain reaction in Haryana, India. Vet World. 2020;13(11):2411–5. doi: 10.14202/vetworld.2020.2411-2415 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Rojas P, Monahan AM, Schuller S, Miller IS, Markey BK, Nally JE. Detection and quantification of leptospires in urine of dogs: a maintenance host for the zoonotic disease leptospirosis. Eur J Clin Microbiol Infect Dis. 2010;29(10):1305–9. doi: 10.1007/s10096-010-0991-2 [DOI] [PubMed] [Google Scholar]
  • 46.Sant’anna R, Vieira AS, Grapiglia J, Lilenbaum W. High number of asymptomatic dogs as leptospiral carriers in an endemic area indicates a serious public health concern. Epidemiol Infect. 2017;145(9):1852–4. doi: 10.1017/S0950268817000632 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Zaidi S, Bouam A, Bessas A, Hezil D, Ghaoui H, Ait-Oudhia K, et al. Urinary shedding of pathogenic Leptospira in stray dogs and cats, Algiers: A prospective study. PLoS One. 2018;13(5):e0197068. doi: 10.1371/journal.pone.0197068 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Gamage CD, Sykes JE, Athapattu TPJ, Senerathne P, Karunadasa U, Fuward M, et al. Isolation of Leptospira licerasiae, Leptospira interrogans and Leptospira kmetyi From Apparently Healthy Companion Dogs Vaccinated for Leptospirosis. Vet Med Sci. 2025;11(3):e70375. doi: 10.1002/vms3.70375 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Grippi F, Cannella V, Macaluso G, Blanda V, Emmolo G, Santangelo F, et al. Serological and Molecular Evidence of Pathogenic Leptospira spp. in Stray Dogs and Cats of Sicily (South Italy), 2017-2021. Microorganisms. 2023;11(2):385. doi: 10.3390/microorganisms11020385 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Guzmán DA, Diaz E, Sáenz C, Álvarez H, Cueva R, Zapata-Ríos G, et al. Domestic dogs in indigenous Amazonian communities: Key players in Leptospira cycling and transmission?. PLoS Negl Trop Dis. 2024;18(4):e0011671. doi: 10.1371/journal.pntd.0011671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Mazzotta E, Lucchese L, Corrò M, Ceglie L, Danesi P, Capello K, et al. Zoonoses in dog and cat shelters in North-East Italy: update on emerging, neglected and known zoonotic agents. Front Vet Sci. 2024;11:1490649. doi: 10.3389/fvets.2024.1490649 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Merker Breyer G, Noronha Arechavaleta N, Corrêa da Silva B, Rocha Jacques da Silva ME, Costa Torres M, Cadó Nemitz L, et al. Canine Leptospirosis in Flood-Affected Areas of Southern Brazil: Molecular Assessment and Public Health Implications. Infect Dis Rep. 2025;17(3):63. doi: 10.3390/idr17030063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Orlando SA, Mora-Jaramillo N, Paredes-Núñez D, Rodriguez-Pazmiño AS, Carvajal E, León Sosa A, et al. Leptospirosis outbreak in Ecuador in 2023: A pilot study for surveillance from a One Health perspective. One Health. 2024;19:100948. doi: 10.1016/j.onehlt.2024.100948 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Perez-Garcia J, Monroy FP, Agudelo-Florez P. Canine Leptospirosis in a Northwestern Region of Colombia: Serological, Molecular and Epidemiological Factors. Pathogens. 2022;11(9):1040. doi: 10.3390/pathogens11091040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Puentes MMM, Camargo KDJ, Roberto YAM, Guzman-Barragan BL, Tafur-Gomez GA, Clavijo NFS. Infection and re-infection of Leptospira spp. in stray dogs and cats from Bogota, Colombia. Vet World. 2024;17(5):973–80. doi: 10.14202/vetworld.2024.973-980 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Sarangi S, Vijaya Bharathi M, Madhanmohan M, Meenambigai TV, Soundararajan C, Manimaran K, et al. Molecular and serological detection of acute canine leptospirosis and associated predictive risk factors in and around Chennai, India. Microb Pathog. 2025;198:107120. doi: 10.1016/j.micpath.2024.107120 [DOI] [PubMed] [Google Scholar]
  • 57.Silva-Ramos CR, Lemaitre G P, Mejorano-Fonseca JA, Matiz-González JM, Aricapa-Giraldo HJ, Agudelo JC, et al. Molecular Evidence of Leptospira spp. Infection Among Household Dogs From 15 Municipalities of the Department of Caldas, Colombia. Zoonoses Public Health. 2025;72(2):215–22. doi: 10.1111/zph.13204 [DOI] [PubMed] [Google Scholar]
  • 58.Alashraf AR, Lau SF, Khairani-Bejo S, Khor KH, Ajat M, Radzi R, et al. First report of pathogenic Leptospira spp. isolated from urine and kidneys of naturally infected cats. PLoS One. 2020;15(3):e0230048. doi: 10.1371/journal.pone.0230048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Bourassi E, Savidge C, Foley P, Hartwig S. Serologic and urinary survey of exposure to Leptospira species in a feral cat population of Prince Edward Island, Canada. J Feline Med Surg. 2021;23(12):1155–61. doi: 10.1177/1098612X211001042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Chan K-W, Hsu Y-H, Hu W-L, Pan M-J, Lai J-M, Huang K-C, et al. Serological and PCR detection of feline leptospira in southern Taiwan. Vector Borne Zoonotic Dis. 2014;14(2):118–23. doi: 10.1089/vbz.2013.1324 [DOI] [PubMed] [Google Scholar]
  • 61.Donato G, Masucci M, Hartmann K, Goris MGA, Ahmed AA, Archer J, et al. Leptospira spp. Prevalence in Cats from Southern Italy with Evaluation of Risk Factors for Exposure and Clinical Findings in Infected Cats. Pathogens. 2022;11(10):1129. doi: 10.3390/pathogens11101129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Dorsch R, Ojeda J, Salgado M, Monti G, Collado B, Tomckowiack C, et al. Cats shedding pathogenic Leptospira spp.-An underestimated zoonotic risk? PLoS One. 2020;15(10):e0239991. doi: 10.1371/journal.pone.0239991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Holzapfel M, Taraveau F, Djelouadji Z. Serological and molecular detection of pathogenic Leptospira in domestic and stray cats on Reunion Island, French Indies. Epidemiol Infect. 2021;149:e229. doi: 10.1017/S095026882100176X [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Kakita T, Kuba Y, Kyan H, Okano S, Morita M, Koizumi N. Molecular and serological epidemiology of Leptospira infection in cats in Okinawa Island, Japan. Sci Rep. 2021;11(1):10365. doi: 10.1038/s41598-021-89872-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Murillo A, Cuenca R, Serrano E, Marga G, Ahmed A, Cervantes S, et al. Leptospira Detection in Cats in Spain by Serology and Molecular Techniques. Int J Environ Res Public Health. 2020;17(5):1600. doi: 10.3390/ijerph17051600 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Rodriguez J, Blais M-C, Lapointe C, Arsenault J, Carioto L, Harel J. Serologic and urinary PCR survey of leptospirosis in healthy cats and in cats with kidney disease. J Vet Intern Med. 2014;28(2):284–93. doi: 10.1111/jvim.12287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Weis S, Rettinger A, Bergmann M, Llewellyn JR, Pantchev N, Straubinger RK, et al. Detection of Leptospira DNA in urine and presence of specific antibodies in outdoor cats in Germany. J Feline Med Surg. 2017;19(4):470–6. doi: 10.1177/1098612X16634389 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Dybing NA, Jacobson C, Irwin P, Algar D, Adams PJ. Leptospira Species in Feral Cats and Black Rats from Western Australia and Christmas Island. Vector Borne Zoonotic Dis. 2017;17(5):319–24. doi: 10.1089/vbz.2016.1992 [DOI] [PubMed] [Google Scholar]
  • 69.Paim MG, Rivas BB, Sebastião GA, Kaefer K, Rodrigues RO, Mayer FQ, et al. Investigation of anti-Leptospira spp. antibodies and leptospiruria in cats attended to a veterinary teaching hospital in southern Brazil. Comp Immunol Microbiol Infect Dis. 2024;107:102138. doi: 10.1016/j.cimid.2024.102138 [DOI] [PubMed] [Google Scholar]
  • 70.Ulsenheimer BC, Tonin AA, von Laer AE, Dos Santos HF, Sangioni LA, Fighera R, et al. Molecular detection and phylogenetic analysis of Leptospira interrogans and Leptospira borgpetersenii in cats from Central region of Rio Grande do Sul state, Brazil. Comp Immunol Microbiol Infect Dis. 2025;116:102286. doi: 10.1016/j.cimid.2024.102286 [DOI] [PubMed] [Google Scholar]
  • 71.Zakeri S, Khorami N, Ganji ZF, Sepahian N, Malmasi A-A, Gouya MM, et al. Leptospira wolffii, a potential new pathogenic Leptospira species detected in human, sheep and dog. Infect Genet Evol. 2010;10(2):273–7. doi: 10.1016/j.meegid.2010.01.001 [DOI] [PubMed] [Google Scholar]
  • 72.Boonsilp S, Thaipadungpanit J, Amornchai P, Wuthiekanun V, Chierakul W, Limmathurotsakul D, et al. Molecular detection and speciation of pathogenic Leptospira spp. in blood from patients with culture-negative leptospirosis. BMC Infect Dis. 2011;11:338. doi: 10.1186/1471-2334-11-338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Tamura KSG, Kumar S. Mega 11: Molecular Evolutionary Genetics Analysis. 2021. [Google Scholar]
  • 74.Letunic I, Bork P. Interactive Tree of Life (iTOL) v6: recent updates to the phylogenetic tree display and annotation tool. Nucleic Acids Res. 2024;52(W1):W78–82. doi: 10.1093/nar/gkae268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Team RC. R: A language and environment for statistical computing. 4.0.3 ed. Vienna, Austria: R Foundation for Statistical Computing. 2020. [Google Scholar]
  • 76.Aragon TJ, Omidpanah A. Tools for training and practicing epidemiologists including methods for two-way and multi-way contingency tables. 2020. [Google Scholar]
  • 77.Chutinantakul ACP, Buathong R. Outbreaks of leptospirosis after a flood in Thung Song District, Nakhon Si Thammarat, January 2017. Dis Control J. 2019;45:317–29. doi: 10.14456/dcj.2019.30 [DOI] [Google Scholar]
  • 78.Ehelepola NDB, Ariyaratne K, Dissanayake DS. The interrelationship between meteorological parameters and leptospirosis incidence in Hambantota district, Sri Lanka 2008-2017 and practical implications. PLoS One. 2021;16(1):e0245366. doi: 10.1371/journal.pone.0245366 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Hinjoy S, Kongyu S, Doung-Ngern P, Doungchawee G, Colombe SD, Tsukayama R, et al. Environmental and Behavioral Risk Factors for Severe Leptospirosis in Thailand. Trop Med Infect Dis. 2019;4(2):79. doi: 10.3390/tropicalmed4020079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Kakita T, Okano S, Kyan H, Miyahira M, Taira K, Kitashoji E, et al. Laboratory diagnostic, epidemiological, and clinical characteristics of human leptospirosis in Okinawa Prefecture, Japan, 2003-2020. PLoS Negl Trop Dis. 2021;15(12):e0009993. doi: 10.1371/journal.pntd.0009993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Philip N, Ahmed K. Leptospirosis in Malaysia: current status, insights, and future prospects. J Physiol Anthropol. 2023;42(1):30. doi: 10.1186/s40101-023-00347-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Sato Y, Hermawan I, Kakita T, Okano S, Imai H, Nagai H, et al. Analysis of human clinical and environmental Leptospira to elucidate the eco-epidemiology of leptospirosis in Yaeyama, subtropical Japan. PLoS Negl Trop Dis. 2022;16(3):e0010234. doi: 10.1371/journal.pntd.0010234 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Thaipadungpanit J, Wuthiekanun V, Chierakul W, Smythe LD, Petkanchanapong W, Limpaiboon R, et al. A dominant clone of Leptospira interrogans associated with an outbreak of human leptospirosis in Thailand. PLoS Negl Trop Dis. 2007;1(1):e56. doi: 10.1371/journal.pntd.0000056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Zhang R, Zhou W, Ye Q, Song S, Wang Y, Xu Y, et al. Comparative genomic analysis of Chinese human leptospirosis vaccine strain and circulating isolate. Hum Vaccin Immunother. 2020;16(6):1345–53. doi: 10.1080/21645515.2020.1720439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Della Rossa P, Tantrakarnapa K, Sutdan D, Kasetsinsombat K, Cosson J-F, Supputamongkol Y, et al. Environmental factors and public health policy associated with human and rodent infection by leptospirosis: a land cover-based study in Nan province, Thailand. Epidemiol Infect. 2016;144(7):1550–62. doi: 10.1017/S0950268815002903 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Putz EJ, Sivasankaran SK, Fernandes LGV, Brunelle B, Lippolis JD, Alt DP, et al. Distinct transcriptional profiles of Leptospira borgpetersenii serovar Hardjo strains JB197 and HB203 cultured at different temperatures. PLoS Negl Trop Dis. 2021;15(4):e0009320. doi: 10.1371/journal.pntd.0009320 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Roberts MW, Smythe L, Dohnt M, Symonds M, Slack A. Serologic-based investigation of leptospirosis in a population of free-ranging eastern grey kangaroos (Macropus giganteus) indicating the presence of Leptospira weilii serovar Topaz. J Wildl Dis. 2010;46(2):564–9. doi: 10.7589/0090-3558-46.2.564 [DOI] [PubMed] [Google Scholar]
  • 88.Slack AT, Symonds ML, Dohnt MF, Corney BG, Smythe LD. Epidemiology of Leptospira weilii serovar Topaz infections in Australia. Commun Dis Intell Q Rep. 2007;31(2):216–22. doi: 10.33321/cdi.2007.31.19 [DOI] [PubMed] [Google Scholar]
  • 89.Stone NE, Hall CM, Ortiz M, Hutton SM, Santana-Propper E, Celona KR, et al. Diverse lineages of pathogenic Leptospira species are widespread in the environment in Puerto Rico, USA. PLoS Negl Trop Dis. 2022;16(5):e0009959. doi: 10.1371/journal.pntd.0009959 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Masuzawa T, Sakakibara K, Saito M, Hidaka Y, Villanueva SYAM, Yanagihara Y, et al. Characterization of Leptospira species isolated from soil collected in Japan. Microbiol Immunol. 2018;62(1):55–9. doi: 10.1111/1348-0421.12551 [DOI] [PubMed] [Google Scholar]
  • 91.Chaiwattanarungruengpaisan S, Thepapichaikul W, Paungpin W, Ketchim K, Suwanpakdee S, Thongdee M. Potentially Pathogenic Leptospira in the Environment of an Elephant Camp in Thailand. Trop Med Infect Dis. 2020;5(4):183. doi: 10.3390/tropicalmed5040183 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Krairojananan P, Thaipadungpanit J, Leepitakrat S, Monkanna T, Wanja EW, Schuster AL, et al. Low Prevalence of Leptospira Carriage in Rodents in Leptospirosis-Endemic Northeastern Thailand. Trop Med Infect Dis. 2020;5(4):154. doi: 10.3390/tropicalmed5040154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Zakeri S, Sepahian N, Afsharpad M, Esfandiari B, Ziapour P, Djadid ND. Molecular epidemiology of leptospirosis in northern Iran by nested polymerase chain reaction/restriction fragment length polymorphism and sequencing methods. Am J Trop Med Hyg. 2010;82(5):899–903. doi: 10.4269/ajtmh.2010.09-0721 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Djadid ND, Ganji ZF, Gouya MM, Rezvani M, Zakeri S. A simple and rapid nested polymerase chain reaction-restriction fragment length polymorphism technique for differentiation of pathogenic and nonpathogenic Leptospira spp. Diagn Microbiol Infect Dis. 2009;63(3):251–6. doi: 10.1016/j.diagmicrobio.2008.10.017 [DOI] [PubMed] [Google Scholar]
  • 95.Rahman S, Paul SK, Aung MS, Ahmed S, Haque N, Raisul MNI, et al. Predominance of Leptospira wolffii in north-central Bangladesh, 2019. New Microbes New Infect. 2020;38:100765. doi: 10.1016/j.nmni.2020.100765 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Matthias MA, Ricaldi JN, Cespedes M, Diaz MM, Galloway RL, Saito M, et al. Human leptospirosis caused by a new, antigenically unique Leptospira associated with a Rattus species reservoir in the Peruvian Amazon. PLoS Negl Trop Dis. 2008;2(4):e213. doi: 10.1371/journal.pntd.0000213 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Tsuboi M, Koizumi N, Hayakawa K, Kanagawa S, Ohmagari N, Kato Y. Imported Leptospira licerasiae Infection in Traveler Returning to Japan from Brazil. Emerg Infect Dis. 2017;23(3):548–9. doi: 10.3201/eid2303.161262 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Steinrigl A, Willixhofer D, Schindler M, Richter S, Unterweger C, Ahmed AA, et al. Isolation and characterization of Leptospira licerasiae in Austrian swine - a first-time case report in Europe. BMC Vet Res. 2024;20(1):348. doi: 10.1186/s12917-024-04213-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013421.r001

Decision Letter 0

Brianna Beechler

28 Sep 2025

PNTD-D-25-01286Pathogenic Leptospira species identified in dogs and cats during neutering in ThailandPLOS Neglected Tropical Diseases Dear Dr. Thaipadungpanit, Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 30 days Nov 27 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Brianna R Beechler, Ph.D., DVMAcademic EditorPLOS Neglected Tropical Diseases Stuart BlacksellSection EditorPLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Additional Editor Comments (if provided): Two reviewers have several minor suggested revisions on things that should be clarified in the methods or discussed briefly and/or some details that may be better placed in supplement. Please respond to their concerns and queries. Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The article has the aim to investigate Leptospira infection in dogs and cats in three regions in Thailand and to provide epidemiological data for the purpose of control and prevention of the infection.

The abstract gives the methods used and results of the study. The title recalls the key features of the article and does not add anything more to the findings of the study.

The references are cited correctly and are mostly recent (20 out of 98 are dated before 2015).

The introduction briefly summarizes the current knowledge about the epidemiology of leptospirosis, citing papers reporting data from different countries and referred on studies on dogs and cats.

The introductive part clearly defines the purpose of the research as indicated in the abstract.

The paper presents a cross-sectional study based on samples collected in three different regions in Thailand.

The study design, the criteria for sampling and the methods used are clearly described. The molecular tests are known and supported by references.

The statistical methods are clearly defined.

Reviewer #2: The objectives, experimental design, sampling, and statistical model are compatible with the proposed study. However, a few details regarding the sampling require further information (specifically on the intermittency of bacterial shedding and sample preservation).

Reviewer #3: Yes

Yes

N/A

Yes

Yes

Yes

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: The data are presented appropriately: tables and figures are clear with titles, columns and rows labelled correctly and clearly.

The text summarizes briefly the contents of the tables but it is not repetitive.

Reviewer #2: The results are compatible with the proposed hypothesis; however, due to the characteristics of the clinical stage of the disease (the leptospiruria phase), intermittent bacterial shedding in the urine may occur. Therefore, the authors need to, at a minimum, mention that the results may be underestimated.

Reviewer #3: Please ref the reviewer comments attached

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: In the first part of the discussion, a number of papers on the prevalence of Leptospira infection in different countries are cited. The authors are conscious (see lines 327-328) that comparisons between results of different studies are not always possible and that variations depends from a number of factors. Moreover, the authors must be careful with the use of term “prevalence” when they refer to the figures from countries they have considered.

In the following sections the results are discussed and placed correctly into context and are not overinterpreted; the conclusions answer the aims of the study and are supported by results.

The authors are aware of the limit of their research considering that the sample size is not equally distributed across all investigated sites and that only a proportion of positive samples were subjected to species identification: this is due to limitations inherent to the sample quality and the methods adopted.

Reviewer #2: The conclusions are consistent with the stated objectives.

Reviewer #3: Please refer to the reviewer comments attached.

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: No

Reviewer #3: Please refer to the reviewer comments attached.

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: The study, despite the limits specified, gives valuable insights suggesting region-specific mitigation strategies to reduce the risk of Leptospira transmission.

Reviewer #2: To the Authors,

First and foremost, I would like to congratulate you on the results obtained, particularly given the substantial sample size. The results are strongly supported by the techniques employed and are, likewise, carefully discussed.

However, a few minor observations and questions need to be clarified in the manuscript:

Positive PCR results from urine samples indicate that the animal is in the leptospiruria phase. However, as bacterial shedding is intermittent during this phase—that is, inconsistent over time—negative results do not allow one to conclude that the patient is not a carrier. This information should be included in the discussion, noting that the results may be underestimated; in other words, the detection frequency could be higher than reported.

Were any of the animals under preoperative treatment (antibiotic therapy)? The administration of antibiotics prior to sample collection may lead to false-negative PCR results.

Was any buffer (e.g., PBS) used to stabilize the urinary pH immediately after collection? DNA extraction from urine can be interfered with by several factors and may even be rendered unviable. As urine pH is acidic, it is important to mix it with PBS immediately after collection to neutralize it.

What was the time elapsed between sample collection and DNA extraction? If DNA is not extracted on the same day, it is recommended that the urine (with stabilized pH) be stored at 5°C and the DNA extracted within the next 24 hours. What procedure was adopted in the study?

I believe these points need to be clarified within the study.

Once again, congratulations on your work.

Reviewer #3: Please refer to the reviewer comments attached.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Chandika Damesh Gamage

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, we strongly recommend that you use PLOS’s NAAS tool (https://ngplosjournals.pagemajik.ai/artanalysis) to test your figure files. NAAS can convert your figure files to the TIFF file type and meet basic requirements (such as print size, resolution), or provide you with a report on issues that do not meet our requirements and that NAAS cannot fix.

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Attachment

Submitted filename: Reviewer Comments PNTD-D-25-01286.docx

pntd.0013421.s006.docx (26.5KB, docx)
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013421.r003

Decision Letter 1

Brianna Beechler

6 Jan 2026

Dear Dr. Thaipadungpanit,

We are pleased to inform you that your manuscript 'Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Brianna R Beechler, Ph.D., DVM

Academic Editor

PLOS Neglected Tropical Diseases

Elsio Wunder Jr

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013421.r004

Acceptance letter

Brianna Beechler

Dear Dr. Thaipadungpanit,

We are delighted to inform you that your manuscript, "Pathogenic Leptospira species identified in dogs and cats during neutering in Thailand," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

For Research Articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Identification of Leptospira species.

    (DOCX)

    pntd.0013421.s001.docx (114.4KB, docx)
    S2 File. Annual case and morbidity rate of study sites reported to the Department of Disease Control, Ministry of Public Health of Thailand, between 2019 and 2022.

    (DOCX)

    pntd.0013421.s002.docx (26.3KB, docx)
    S1 Table. Demography characteristics of dogs and cats with urine specimens PCR-positive for pathogenic Leptospira.

    (XLSX)

    pntd.0013421.s003.xlsx (72.6KB, xlsx)
    S2 Table. List of reference rrs sequences used for the 16S rRNA sequence analysis.

    (XLSX)

    pntd.0013421.s004.xlsx (68.4KB, xlsx)
    S3 Table. Frequency of Leptospira groups in dogs and cats stratified by study site, age group, sex, and owned status.

    (DOCX)

    pntd.0013421.s005.docx (33KB, docx)
    Attachment

    Submitted filename: Reviewer Comments PNTD-D-25-01286.docx

    pntd.0013421.s006.docx (26.5KB, docx)
    Attachment

    Submitted filename: ResponseToReviewers_20260105_V5.3.docx

    pntd.0013421.s008.docx (283.7KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES